HUMAN INTERFERON-INDUCIBLE PROTEIN-10 IS A POTENT INHIBITOR OF ANGIOGENESIS IN-VIVO

被引:585
|
作者
ANGIOLILLO, AL
SGADARI, C
TAUB, DD
LIAO, F
FARBER, JM
MAHESHWARI, S
KLEINMAN, HK
REAMAN, GH
TOSATO, G
机构
[1] CHILDRENS NATL MED CTR,DEPT HEMATOL ONCOL,WASHINGTON,DC 20010
[2] US FDA,CTR BIOL EVALUAT & RES,DIV HEMATOL PROD,BETHESDA,MD 20892
[3] NCI,FREDERICK CANC RES & DEV CTR,MOLEC IMMUNOREGULAT LAB,FREDERICK,MD 21702
[4] NIAID,CLIN INVEST LAB,BETHESDA,MD 20892
[5] NIDR,DEV BIOL LAB,BETHESDA,MD 20892
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1995年 / 182卷 / 01期
关键词
D O I
10.1084/jem.182.1.155
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human interferon-inducible protein 10 (IP-10), a member of the alpha chemokine family, inhibits bone marrow colony formation, has antitumor activity in vivo, is chemoattractant for human monocytes and T cells, and promotes T cell adhesion to endothelial cells. Here we report that IP-10 is a potent inhibitor of angiogenesis in vivo. IP-10 profoundly inhibited basic fibroblast growth factor-induced neovascularization of Matrigel (prepared by H. K. Kleinman) injected subcutaneously into athymic mice. In addition, IP-10, in a dose-dependent fashion, suppressed endothelial cell differentiation into tubular capillary structures in vitro. IP-10 had no effect on endothelial cell growth, attachment, and migration as assayed in vitro. These results document an important biological property of IP-10 and raise the possibility that IP-10 may participate in the regulation of angiogenesis during inflammation and tumorigenesis.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 50 条
  • [11] Increased expression of interferon-inducible protein-10 during surgically induced peritoneal injury
    Mrstik, M
    Kotseos, K
    Ma, C
    Chegini, N
    [J]. WOUND REPAIR AND REGENERATION, 2003, 11 (02) : 120 - 126
  • [12] Induction of interferon-inducible protein-10 and monokine induced by interferon-γ from human endothelial cells infected with Influenza A virus
    Ishiguro, N
    Takada, A
    Yoshioka, M
    Ma, X
    Kikuta, H
    Kida, H
    Kobayashi, K
    [J]. ARCHIVES OF VIROLOGY, 2004, 149 (01) : 17 - 34
  • [13] Induction of interferon-inducible protein-10 and monokine induced by interferon-γ from human endothelial cells infected with Influenza A virus
    N. Ishiguro
    A. Takada
    M. Yoshioka
    X. Ma
    H. Kikuta
    H. Kida
    K. Kobayashi
    [J]. Archives of Virology, 2003, 149 : 17 - 34
  • [14] HIV-1 induction of interferon-inducible protein-10 (IP-10) in microglia.
    Morgan, AC
    Si, Q
    Lee, SC
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (05): : 464 - 464
  • [15] Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10
    Sgadari, C
    Angiolillo, AL
    Tosato, G
    [J]. BLOOD, 1996, 87 (09) : 3877 - 3882
  • [16] A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12
    Angiolillo, AL
    Sgadari, C
    Tosato, G
    [J]. INERLEUKIN 12: CELLULAR AND MOLECULAR IMMUNOLOGY OF AN IMPORTANT REGULATORY CYTOKINE, 1996, 795 : 158 - 167
  • [17] Human recombinant interferon-inducible protein-10 inhibits proliferation of immature normal and acute myelogenous leukemia progenitors.
    Sarris, AH
    Talpaz, M
    Deisseroth, AB
    Estrov, Z
    [J]. BLOOD, 1995, 86 (10) : 2074 - 2074
  • [18] The angiostatic activity of interferon-inducible protein-10/CXCL10 in human melanoma depends on binding to CXCR3 but not to glycosaminoglycan
    Yang, JM
    Richmond, A
    [J]. MOLECULAR THERAPY, 2004, 9 (06) : 846 - 855
  • [19] Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response
    Wang, XK
    Yue, TL
    Ohlstein, EH
    Sung, CP
    Feuerstein, GZ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 24286 - 24293
  • [20] Interferon-Inducible Protein-10 as a Marker to Detect Latent Tuberculosis Infection in Patients with Inflammatory Rheumatic Diseases
    Ortakoylu, Mediha Gonenc
    Bahadir, Ayse
    Iliaz, Sinem
    Bugdayci, Derya Soy
    Uysal, Mehmet Atilla
    Paker, Nurdan
    Onur, Seda Tural
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (07):